BERNSTEIN HOWARD PHD MD 4
4 · SQZ Biotechnologies Co · Filed Jan 26, 2023
Insider Transaction Report
Form 4
BERNSTEIN HOWARD PHD MD
Chief Scientific Officer
Transactions
- Award
Stock Option
2023-01-24+830,000→ 830,000 totalExercise: $0.73Exp: 2033-01-24→ Common Stock (830,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.